In conclusion, our results demonstrated that beyond its canonical enzyme activities, PRDX6 promotes the malignant progression of ovarian cancer through a nonenzymatic mechanism, by which PRDX6 interacts with NNMT and suppresses TRIM56‐mediated ubiquitination degradation of NNMT. Here, NNMT is linked to ovarian carcinoma.